Alignment Healthcare, Inc. (ALHC) Tops Q2 EPS by 14c
Alignment Healthcare, Inc. (NASDAQ: ALHC) reported Q2 EPS of $0.07, $0.14 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $1 billion versus the consensus estimate of $960.51 million.
Outlook for Third Quarter and Fiscal Year 2025
| Three Months Ending September 30, 2025 | Twelve Months Ending December 31, 2025 | |||||||
| $ Millions | Low | High | Low | High | ||||
| Health Plan Membership | 225,000 | 227,000 | 229,000 | 234,000 | ||||
| Revenue | $970 | $985 | $3,885 | $3,910 | ||||
| Adjusted Gross Profit(1) | $106 | $114 | $452 | $469 | ||||
| Adjusted EBITDA(1) | $5 | $13 | $69 | $83 | ||||
_______________________
(1) Adjusted gross profit and adjusted EBITDA are non-GAAP financial measures presented as supplemental disclosure. We cannot provide estimated ranges for the most directly comparable GAAP measures without unreasonable efforts because of the uncertainty around certain items that may impact such GAAP measures, including equity-based compensation expense and depreciation and amortization, that are not within our control or cannot be reasonably predicted. See “Second Quarter 2025 Non-GAAP Reconciliation Tables” for additional information.
For earnings history and earnings-related data on Alignment Healthcare, Inc. (ALHC) click here.